🇬🇧 Lumoxiti in United Kingdom

Lumoxiti (MOXETUMOMAB PASUDOTOX) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: likely_approved

Lumoxiti in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Lumoxiti approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Lumoxiti in United Kingdom?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.